Marc Feldmann

Marc Feldmann. He is an Australian-born immunologist renowned for his groundbreaking work in understanding the role of cytokines in autoimmune diseases. Together with his long-time collaborator Ravinder N. Maini, he pioneered the development of anti-TNF therapy, a revolutionary treatment for conditions like rheumatoid arthritis and Crohn's disease. His research transformed the field of clinical immunology and established a new paradigm for treating chronic inflammatory disorders.

Early life and education

Born in 1944 in Zagreb during the era of the Independent State of Croatia, his family later emigrated to Australia. He pursued his higher education in his adopted country, earning a Bachelor of Science degree from the University of Melbourne. He then completed his medical training at the University of Sydney, qualifying with an MB BS. His early academic foundation in Australia set the stage for his future research career, leading him to undertake postdoctoral work in the United Kingdom.

Career and research

His research career became defined by his work at the Kennedy Institute of Rheumatology in London, where he collaborated closely with Ravinder N. Maini. Their investigations focused on the pathogenesis of rheumatoid arthritis, a debilitating autoimmune disease. They identified tumor necrosis factor alpha (TNF-α) as a key cytokine driving the destructive inflammation in the joints. This critical discovery, published in seminal papers, demonstrated that blocking this molecule could alleviate disease symptoms. This work led directly to the clinical development of infliximab and adalimumab, which are monoclonal antibody therapies that inhibit TNF. He later became a professor at Imperial College London, furthering research into immunology and biologics. His work extended the potential of anti-TNF therapy to other conditions, including psoriasis, ankylosing spondylitis, and inflammatory bowel disease.

Awards and honors

His transformative contributions to medicine have been recognized with numerous prestigious international awards. In 2003, he and Ravinder N. Maini received the Lasker-DeBakey Clinical Medical Research Award, often considered America's highest biomedical research honor. The Royal Society awarded him the Royal Medal in 2010. In 2013, he shared the Crafoord Prize in Polyarthritis with Maini, an award granted by the Royal Swedish Academy of Sciences for disciplines not covered by the Nobel Prize. He is a elected a Fellow of the Royal Society (FRS) and a Fellow of the Academy of Medical Sciences. Other notable honors include the Dr. Paul Janssen Award for Biomedical Research and the Ernst Schering Prize.

Personal life

He maintains a strong connection to his adopted home of the United Kingdom, where he has spent the majority of his professional career. Details regarding his family life are kept private. He is known within the scientific community for his dedicated and collaborative approach to research, exemplified by his decades-long partnership with Ravinder N. Maini. His work has required extensive collaboration with pharmaceutical companies like Johnson & Johnson and AbbVie to translate laboratory discoveries into widely available therapies.

Legacy and impact

The legacy of his work is profound, having ushered in the era of biologic therapy for autoimmune diseases. The concept of cytokine blockade, proven successful with anti-TNF drugs, has become a fundamental strategy in clinical immunology, inspiring therapies targeting other molecules like interleukin-6 and interleukin-17. His research provided a definitive model of translational research, moving from basic laboratory science to global clinical application. This has alleviated suffering for millions of patients worldwide with rheumatoid arthritis, Crohn's disease, and other inflammatory conditions. His career stands as a landmark example of how focused investigation into disease mechanisms can yield transformative medical treatments.

Category:Australian immunologists Category:British immunologists Category:1944 births Category:Lasker Award recipients Category:Fellows of the Royal Society